Header Logo

Connection

Ben Marafino to Recombinant Proteins

This is a "connection" page, showing publications Ben Marafino has written about Recombinant Proteins.
Connection Strength

0.239
  1. Commercial development considerations for biotechnology-derived therapeutics. Cardiovasc Toxicol. 2003; 3(1):5-12.
    View in: PubMed
    Score: 0.218
  2. The role of oxidant injury in tumor cell sensitivity to recombinant human tumor necrosis factor in vivo. Implications for mechanisms of action. J Immunol. 1989 Feb 15; 142(4):1405-9.
    View in: PubMed
    Score: 0.021

© 2025 Kaiser Permanente